Bio-Techne
TECH
245 hedge funds and large institutions have $3.19B invested in Bio-Techne in 2013 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 93 increasing their positions, 99 reducing their positions, and 24 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
23% more capital invested
Capital invested by funds: $2.6B → $3.19B (+$590M)
6% less repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 99
1% less funds holding
Funds holding: 248 → 245 (-3)
13% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$44.4M |
| 2 |
William Blair & Company
Chicago,
Illinois
|
+$34.5M |
| 3 |
RIM
RS Investment Management
San Francisco,
California
|
+$30.7M |
| 4 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$19.8M |
| 5 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
+$18.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$26.1M |
| 2 |
Schroder Investment Management Group
London,
United Kingdom
|
-$22.7M |
| 3 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$19.7M |
| 4 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
-$19.5M |
| 5 |
O
OrbiMed
New York
|
-$18.7M |
TECH Hedge Fund Activity: Q4 2013 in Review
245 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Bio-Techne (TECH) for Q4 2013, worth a combined $3.19B — up 23% from $2.6B a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of TECH and 21 opened new positions — a net loss of 3 holders — while 99 trimmed existing stakes and 93 added.
The largest buyer was First Trust Advisors, adding an estimated $44.4M. The largest seller was Morgan Stanley, cutting an estimated $26.1M.
- 245 institutional investors held Bio-Techne (TECH) as of Q4 2013, down from 248 in Q3 2013.
- Funds reported $3.19B of Bio-Techne stock for Q4 2013, up 23% quarter-over-quarter.
- 21 funds opened new Bio-Techne positions in Q4 2013 and 24 closed out, a net change of -3 holders.
- The largest Bio-Techne buyer in Q4 2013 was First Trust Advisors, an estimated $44.4M added.
- The largest Bio-Techne seller in Q4 2013 was Morgan Stanley, an estimated $26.1M sold.
Based on aggregated 13F filings for Q4 2013.